Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15947080.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The prior diagnosis of fatal astrocytoma in a 60-year-old man with Crohn's disease treated with natalizumab, a monoclonal antibody against alpha4 integrins, was reclassified as JC virus-related progressive multifocal leukoencephalopathy (PML). Analysis of frozen serum samples showed that JC virus DNA had appeared in the serum three months after the initiation of open-label natalizumab monotherapy and two months before the appearance of symptomatic PML. There was staining of the brain lesion for polyomavirus. This case report, along with two others, suggests that anti-alpha4-integrin therapy can result in JC virus-induced PML.
Medical subject headings
- Antibodies, Monoclonal
- Crohn Disease
- Integrin alpha4
- JC Virus
- Leukoencephalopathy, Progressive Multifocal
- Opportunistic Infections